Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Am J Physiol Lung Cell Mol Physiol ; 300(1): L102-11, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20971806

RESUMEN

Breathing hyperbaric oxygen (HBO2), particularly at pressures above 3 atmospheres absolute, can cause acute pulmonary injury that is more severe if signs of central nervous system toxicity occur. This is consistent with the activation of an autonomic link between the brain and the lung, leading to acute pulmonary oxygen toxicity. This pulmonary damage is characterized by leakage of fluid, protein, and red blood cells into the alveoli, compatible with hydrostatic injury due to pulmonary hypertension, left atrial hypertension, or both. Until now, however, central hemodynamic parameters and autonomic activity have not been studied concurrently in HBO2, so any hypothetical connections between the two have remained untested. Therefore, we performed experiments using rats in which cerebral blood flow, electroencephalographic activity, cardiopulmonary hemodynamics, and autonomic traffic were measured in HBO2 at 5 and 6 atmospheres absolute. In some animals, autonomic pathways were disrupted pharmacologically or surgically. Our findings indicate that pulmonary damage in HBO2 is caused by an abrupt and significant increase in pulmonary vascular pressure, sufficient to produce barotrauma in capillaries. Specifically, extreme HBO2 exposures produce massive sympathetic outflow from the central nervous system that depresses left ventricular function, resulting in acute left atrial and pulmonary hypertension. We attribute these effects on the heart and on the pulmonary vasculature to HBO2-mediated central sympathetic excitation and catecholamine release that disturbs the normal equilibrium between excitatory and inhibitory activity in the autonomic nervous system.


Asunto(s)
Circulación Cerebrovascular/efectos de los fármacos , Oxigenoterapia Hiperbárica/efectos adversos , Lesión Pulmonar/inducido químicamente , Oxígeno/toxicidad , Animales , Electroencefalografía/efectos de los fármacos , Corazón/efectos de los fármacos , Paro Cardíaco/inducido químicamente , Hemodinámica/efectos de los fármacos , Oxigenoterapia Hiperbárica/métodos , Pulmón/efectos de los fármacos , Circulación Pulmonar/efectos de los fármacos , Ratas , Sistema Nervioso Simpático/efectos de los fármacos
2.
Neurosci Behav Physiol ; 35(7): 751-6, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16433071

RESUMEN

The hypothesis that in conditions of hyperbaric oxygenation, nitric oxide (NO) modulates the vasodilatory effect of CO2 in the brain and thus accelerates the neurotoxic action of oxygen was verified experimentally. Conscious rats breathed atmospheric air or oxygen at 5 atm and blood flow in the striatum was measured before and after inhibition of carbonic anhydrase with acetazolamide, which causes retention of CO2 in the brain. Acetazolamide (35 mg/kg) increased blood flow in the animals when breathing air by 38 +/- 7.4% (p < 0.01), while preliminary inhibition of NO synthase with N(omega)-nitro-L-arginine-methyl ester (L-NAME, 30 mg/kg) significantly weakened its vasodilatory action. Inhibition of carbonic anhydrase in animals breathing hyperbaric oxygen at 5 atm prevented cerebral vasoconstriction, increased brain blood flow, and accelerated the development of oxygen convulsions. The vasodilatory effect of acetazolamide in hyperbaric oxygenation was significantly reduced in animals pretreated with the NO synthase inhibitor, such that the latent period of convulsions increased. The results obtained here provide evidence that in conditions of extreme hyperoxia, NO modulates the cerebral hyperemia developing in conditions of CO2 retention in the brain and accelerates the development of the neurotoxic actions of hyperbaric oxygen.


Asunto(s)
Encéfalo/fisiología , Dióxido de Carbono/metabolismo , Óxido Nítrico/fisiología , Oxígeno/efectos adversos , Presión , Acetazolamida/farmacología , Animales , Encéfalo/efectos de los fármacos , Inhibidores de Anhidrasa Carbónica/farmacología , Cuerpo Estriado/irrigación sanguínea , Cuerpo Estriado/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Electroencefalografía/métodos , Inhibidores Enzimáticos/farmacología , Masculino , NG-Nitroarginina Metil Éster/farmacología , Ratas , Ratas Wistar , Factores de Tiempo
3.
Ross Fiziol Zh Im I M Sechenova ; 101(11): 1279-88, 2015 Nov.
Artículo en Ruso | MEDLINE | ID: mdl-26995956

RESUMEN

The activation of autonomic afferents (achieved through the vagus nerve (VN) electrical stimulation) on CNS O2 toxicity and cardiovascular function was investigated. In conscious rabbits at 5 ATA 02, prodromal signs of CNS O2 toxicity and convulsion latency were determined with and without vagus nerve (VN) stimulation. EEG, ECG and respiration were also recorded. In rabbits at 5 ATA, sympathetic overdrive and specific patterns on the EEG (synchronization of slow-waves), ECG (tachycardia) and respiration (respiratory minute volume increase) preceded motor convulsions. Vagus nerve stimulation increased parasympathetic component of autonomic drive and significantly delayed prodromal signs of oxygen toxicity and convulsion latency. Autonomic afferent input to the brain is a novel target for preventing CNS toxicity in HBO2.


Asunto(s)
Electroencefalografía , Epilepsia/inducido químicamente , Epilepsia/fisiopatología , Oxígeno/toxicidad , Estimulación del Nervio Vago , Nervio Vago/fisiopatología , Animales , Conejos
4.
Neurosci Behav Physiol ; 33(9): 883-8, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14969426

RESUMEN

Studies on conscious rats with inhibition of NO synthase were used to assess the dynamics of brain blood flow and EEG traces during hyperbaric oxygenation at 4 or 5 atm. Oxygen at a pressure of 4 atm induced cerebral vasoconstriction in intact animals and decreased blood flow by 11-18% (p < 0.05) during 60-min exposure to hyperbaric oxygenation. Paroxysmal EEG activity and oxygen convulsions did not occur in rats at 4 atm of O2. At 5 atm, convulsive activity appeared on the EEG at 41 +/- 1.9 min, and blood flow decreased significantly during the first 20 min; blood flow increased by 23 +/- 9%, as compared with controls, (p < 0.01) before the appearance of convulsions on the EEG. Prior inhibition of NO synthase I (NOS I) and NO synthase III (NOS III) with N(omega)-nitro-L-arginine methyl ester (L-NAME, 30 mg/kg) or inhibition only of NOS I with 7-nitroindazole (7-NI, 50 mg/kg) prevented the development of hyperoxic hyperemia and paroxysmal spikes on the EEG during hyperbaric oxygenation at 5 atm. These results show that hyperbaric oxygen induces changes in cerebral blood flow which modulate its neurotoxic action via nitric oxide synthesized both in neurons and in cerebral vessels.


Asunto(s)
Encéfalo/irrigación sanguínea , Circulación Cerebrovascular/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Oxigenoterapia Hiperbárica/efectos adversos , Óxido Nítrico Sintasa/efectos de los fármacos , Oxígeno/toxicidad , Animales , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Cuerpo Estriado/irrigación sanguínea , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/enzimología , Electroencefalografía , Endotelio Vascular/metabolismo , Masculino , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo I , Óxido Nítrico Sintasa de Tipo III , Ratas , Ratas Wistar , Flujo Sanguíneo Regional/efectos de los fármacos , Convulsiones/inducido químicamente , Vasoconstricción/efectos de los fármacos
5.
Neurosci Behav Physiol ; 33(8): 783-7, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14635993

RESUMEN

The hypothesis that decreases in brain blood flow during respiration of hyperbaric oxygen result from inactivation of nitric oxide (NO) by superoxide anions (O2(-)) is proposed. Changes in brain blood flow were assessed in conscious rats during respiration of atmospheric air or oxygen at a pressure of 4 atm after dismutation of O2(-) with superoxide dismutase or suppression of NO synthesis with the NO synthase inhibitor L-NAME. I.v. administration of superoxide dismutase increased brain blood flow in rats breathing air but was ineffective after previous inhibition of NO synthase. Hyperbaric oxygenation at 4 atm induced decreases in brain blood flow, though prior superoxide dismutase prevented hyperoxic vasoconstriction and increased brain blood flow in rats breathing hyperbaric oxygen. The vasodilatory effect of superoxide dismutase in hyperbaric oxygenation was not seen in animals given prior doses of the NO synthase inhibitor. These results provide evidence that one mechanism for hyperoxic vasoconstriction in the brain consists of inactivation of NO by superoxide anions, decreasing its basal vasorelaxing action.


Asunto(s)
Encéfalo/irrigación sanguínea , Hiperoxia/fisiopatología , Óxido Nítrico/metabolismo , Superóxidos/metabolismo , Vasoconstricción , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Depuradores de Radicales Libres/farmacología , Oxigenoterapia Hiperbárica , Masculino , Ratas , Ratas Wistar , Flujo Sanguíneo Regional/efectos de los fármacos , Flujo Sanguíneo Regional/fisiología , Superóxido Dismutasa/farmacología
6.
Neurosci Behav Physiol ; 40(2): 173-8, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20033309

RESUMEN

The physiological role of extracellular superoxide dismutase (SOD3) has received insufficient study. We investigated the hypothesis that SOD3, which neutralizes superoxide anions (O2(-)) in the intercellular space of the brain, prevents the inactivation of nitric oxide (NO) and is thus involved in regulating cerebral vascular tone. Local brain blood flow was measured in the striatum of anesthetized rats during administration of various combinations of a SOD mimetic, a SOD inhibitor, an NO donor, and an NOS inhibitor into the striatum using a Hamilton syringe. In normal conditions, SOD3 was found to minimize O2(-) levels, protecting endogenously produced NO at a sufficient level to maintain cerebral vascular tone and reactivity. SOD3 was found to increase the vasodilatory effect of endogenously produced NO in the brain. SOD3 was found to neutralize superoxide anions produced in the brain during respiration of 100% O2 and to maintain basal NO levels and its vasodilatory potential in normobaric hyperoxia.


Asunto(s)
Encéfalo/irrigación sanguínea , Encéfalo/fisiología , Circulación Cerebrovascular/fisiología , Superóxido Dismutasa/metabolismo , Animales , Vasos Sanguíneos/efectos de los fármacos , Vasos Sanguíneos/enzimología , Vasos Sanguíneos/fisiología , Encéfalo/efectos de los fármacos , Circulación Cerebrovascular/efectos de los fármacos , Cuerpo Estriado/irrigación sanguínea , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/fisiología , Inhibidores Enzimáticos/farmacología , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/fisiología , Hiperoxia/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/metabolismo , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Ratas , S-Nitroso-N-Acetilpenicilamina/farmacología , Superóxido Dismutasa/antagonistas & inhibidores , Superóxidos/metabolismo , Vasodilatación/efectos de los fármacos , Vasodilatación/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA